0.37 USD
▲-0.01+9.68%
盘后 0.33 -0.12%
2026-08-03
市值
$1.28M
市盈率
—
EPS
-5.35
股息率
—
52 周区间
0.31 – 5.30
成交量
2.93M
Beta
1.40
目标价
—
52W 低 0.3152W 高 5.30
价格走势
公司简介
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as ...